Top Markets
#1 ADO Protocol ADO Protocol +194.72%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.67%
#7 Wrapped NXM Wrapped NXM +14.87%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +13.32%
#10 Pons Pons +12.61%
Coin of the day
ADO Protocol ADO Protocol
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Classificação em ações #33738
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Preço da ação
$4.58
Última sincronização: 2025-05-09
Valor de mercado
$6.98M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar NeuroMetrix, Inc. (NURO)

Categoria

Healthcare
Lucros da NeuroMetrix, Inc. (NURO)
Lucros em Dec 2024 TTM: $-7.81M
De acordo com os últimos relatórios financeiros da NeuroMetrix, Inc., os ganhos atuais da empresa são de $-7.81M. Em 2023, a empresa teve ganhos de $-6.53M, uma diminuição em relação a aos ganhos de 2022, que foram de $-4.42M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da NeuroMetrix, Inc. de 2001 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -96,320.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -66,048.81%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -71,365.19%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -49,561.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -18,260.26%
US